• Plant Cell Lysis Buffer: Native Protein Workflow

  2026-09-01

  Build a cold, reproducible workflow for extracting plant proteins while retaining phosphorylation states and native protein interactions. This guide connects Western blotting, immunoprecipitation, co-IP, and ELISA decisions to the MAPK10–KRT16 research framework without confusing published cancer findings with product-specific validation.

• Perphenazine: D2 Antagonist Research Guide

  2026-08-31

  Perphenazine is a dopamine D2 receptor antagonist with additional histamine, muscarinic, and adrenergic receptor activity. Research data support its use in schizophrenia research, mitochondria-mediated cell death induction, opioid tolerance suppression, and exploratory host-directed antibacterial studies.

• Perphenazine: Research Workflows and Applications

  2026-08-31

  Perphenazine combines dopamine D2 receptor antagonism with broader phenothiazine receptor activity, enabling integrated neuropharmacology, mitochondrial, and host-directed immunity studies. This practical guide translates published findings into assay design, control selection, and troubleshooting strategies for reproducible research use.

• Pemetrexed Workflows for Tumor Cell Research

  2026-08-30

  Build reproducible Pemetrexed dose–response assays around folate-pathway biology, controlled exposure, and phenotype-resolved readouts. The workflow also shows how pemetrexed disodium can support malignant mesothelioma model studies that incorporate DNA-repair status without overinterpreting combination-treatment results.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-29

  The reference study introduces gastric cancer assembloids that combine patient-matched tumor organoids with stromal subpopulations, producing a model that better reflects tumor heterogeneity and microenvironmental signaling. Its transcriptomic and drug-response results show that stromal context can reshape inflammatory programs, extracellular-matrix remodeling, and therapeutic sensitivity, supporting more informative personalized cancer biology research.

• Rotigotine hydrochloride: Assay Workflow Guide

  2026-08-29

  This scenario-driven guide shows how Rotigotine hydrochloride (SKU A3777) can be integrated into cell viability, proliferation, cytotoxicity, and neuroprotection workflows. It connects formulation, concentration selection, orthogonal readouts, and Parkinson’s disease model data to practical decisions that improve interpretability.

• Mianserin HCl: Applied Research Workflows

  2026-08-28

  Mianserin HCl supports controlled studies of 5-HT2 receptor signaling, time-dependent phenotypes, and cyclodextrin-enabled exposure. This guide translates clinical pharmacology findings into practical workflows for neuroscience, cytotoxicity, and antipathogenic research while emphasizing formulation controls and assay-specific troubleshooting.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-28

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive reagent for detecting HRP on immunoblots with X-ray film or CCD imaging. It is intended for HRP-based Western blot workflows and should not be used as a substitute for fluorescent or radioisotopic detection methods.

• Fzd5 Links Cholesterol to Wnt Signaling in Cancer

  2026-08-27

  The reference study identifies Frizzled5 (Fzd5) as a cholesterol-sensitive Wnt receptor that connects abnormal lipid metabolism with β-catenin signaling in pancreatic ductal adenocarcinoma. Its findings suggest that cholesterol-dependent receptor maturation and palmitoylation, rather than ligand binding alone, can determine Wnt pathway activity and tumor growth.

• Rotigotine: Dopamine D2/D3 Agonist Research Guide

  2026-08-27

  Rotigotine is a dopamine D2/D3 receptor agonist and dopaminergic signaling pathway modulator used in Parkinson’s disease research. Published rat studies show antidepressant-like activity in forced-swim, learned-helplessness, and olfactory-bulbectomy models, while higher doses can confound behavioral interpretation through increased locomotion.

• Doxycycline hyclate for MMP-2/MMP-9 BBB Research

  2026-08-26

  Doxycycline hyclate functions as a practical matrix metalloproteinases inhibitor for connecting MMP activity with blood-brain barrier failure, neuronal apoptosis, and cognitive phenotypes. This workflow translates an arsenic neurotoxicity study into reproducible formulation, assay-selection, and troubleshooting strategies for neurovascular and intracranial aneurysm research.

• mTORC1 Oscillation Controls Cell-Cycle Transitions

  2026-08-26

  The reference study demonstrates that mTORC1 activity is not constant during proliferation but oscillates between low activity in mitosis and G1 and high activity in S and G2. These phase-specific changes help coordinate interphase progression, G2/M checkpoint satisfaction, and differential sensitivity to autophagy induction.

• BMS 309403: Reliable FABP4 Assay Design

  2026-08-25

  Learn how BMS 309403 (SKU B7794) can support reproducible cell viability, inflammatory, lipid-accumulation, and cytotoxicity workflows. This scenario-based guide connects FABP4 biology with practical concentration selection, vehicle control, endpoint interpretation, and vendor evaluation.

• SARS-CoV-2 N Protein, GADD34, and Innate Immunity

  2026-08-25

  The 2024 Molecules study identifies an atypical stress-granule mechanism by which SARS-CoV-2 nucleocapsid protein suppresses GADD34-dependent innate immunity. Its findings connect GADD34 mRNA sequestration in N+/G3BP1+ foci with impaired IRF3 nuclear localization, providing a mechanistic framework for viral immune evasion and for designing assays that distinguish condensate formation from productive antiviral signaling.

• Bortezomib (PS-341) Experimental Workflows

  2026-08-24

  Bortezomib (PS-341) offers reversible 20S proteasome inhibition for controlled apoptosis assays, cancer-cell profiling, and mechanistic studies of proteostasis. This workflow-focused guide also explains how to use PS-341 as a comparator when investigating the proteasome–ER stress–FOXN1 axis reported in thymic epithelial cells.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page